Published in Cancer Weekly, May 15th, 2001
Intradermal and intralymphatic routes of administration were more likely to induce interferon-gamma production, while intravenous injection was better at generating antigen (Ag)-specific antibodies (Abs), noted L. Fong and colleagues at Stanford University.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.